Radiosensitization of C6 glioma by thymidine and 41.8 degrees C hyperthermia.
The cytotoxic, antiproliferative, and radiosensitizing effects of thymidine (a nucleoside metabolite) were studied using the C6 glioma cell line in vitro. Radiosensitization by a combination of thymidine and 41.8 degrees C hyperthermia was also evaluated. Thymidine concentrations above 100 micrograms/ml completely inhibited C6 proliferation while concentrations of 100 to 1000 micrograms/ml (for up to 24 hours) decreased C6 cell survival to as little as 7.4% compared to untreated control cells. Radiosensitivity was enhanced by the administration of thymidine alone (400 micrograms/ml x 24 hours before irradiation); sensitization by 41.8 degrees C hyperthermia alone (1 hour ending immediately before irradiation) was less pronounced. Thymidine and hyperthermia together produced greater radiosensitization than did heat alone or thymidine alone. These data support the further investigation of thymidine as a neuro-oncology radiosensitizer.
Cohen
J D
JD
Department of Human Oncology and Medicine, University of Wisconsin Hospital and Clinics, Madison.
Robins
H I
HI
Javid
M J
MJ
D000818:Animals; D002460:Cell Line; D005910:Glioma / Q000401:mortality / Q000532:radiotherapy*; D006979:Hyperthermia, Induced; D011829:Radiation Dosage; D011836:Radiation Tolerance / Q000187:drug effects; D011838:Radiation-Sensitizing Agents; D051381:Rats; D015996:Survival Rate; D013936:Thymidine / Q000627:therapeutic use*
D011838:Radiation-Sensitizing Agents; D013936:Thymidine